SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 64 filers reported holding SIO GENE THERAPIES INC in Q4 2020. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $125,000 | – | 45,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cladis Investment Advisory, LLC | 1,104,000 | $1,424,000 | 1.31% |
Prosight Management, LP | 802,180 | $1,035,000 | 0.62% |
Privium Fund Management B.V. | 1,806,542 | $2,367,000 | 0.47% |
Rubric Capital Management LP | 3,000,000 | $3,870,000 | 0.18% |
ACT CAPITAL MANAGEMENT, LLC | 185,000 | $239,000 | 0.17% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,914,000 | $7,629,000 | 0.15% |
APOGEM CAPITAL LLC | 60,245 | $78,000 | 0.05% |
Clearline Capital LP | 218,506 | $282,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 166,806 | $215,000 | 0.03% |
Hudson Bay Capital Management LP | 1,800,000 | $2,322,000 | 0.02% |